Only 9 % had documented asbestos exposure, and genetic testing was limited to 5 patients (1 BAP1 mutation, 1 type 2 neurofibromatosis, 1 Lynch syndrome, 1 McCune-Albright and one negative) [23]. This evidence concerns the gene BAP1 and neurofibromatosis.